Union Minister Dr Jitendra Singh releases India BioEconomy Report 2022: Urges all to work towards $300 billion target by 2030
The report has been prepared for "Make in India Facilitation Cell for Biotechnology" of BIRAC by Association of Biotechnology Led Enterprises (ABLE).
StringBio raises $20 million in Series B funding round
String Bio announced the first closure of its Series B round after raising $20 million (around Rs 156 crore), led by Woodside Energy, with participation from Ankur Capital, Dare Ventures, Redstart and Zenfold Ventures, among other investors.
Biocom California sees India on life sciences radar with its manufacturing prowess and scientific acumen
Joseph Panetta, president & CEO, Biocom California said, “It is India’s infrastructure for manufacture of biologics, biosimilars, qualified pool of scientific human resources and strong intellectual property rights’ (IPR) adherence that have been the three top attractive factors for us to be here and scout for potential opportunities in collaborations. Therefore, we are here to understand the industry, market prospects and engage in discussions with Indian biotech companies.